Bronwen J. Mayo

Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases

Andrea M. Stringer, Noor Al‐Dasooqi, Joanne M. Bowen et al. · Supportive Care in Cancer · 2013 · 130 citations

Inflammation, Chronic Inflammatory Diseases, Dysbiosis +13

Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea

Joanne M. Bowen, Bronwen J. Mayo, Erin Plews et al. · Cancer Biology & Therapy · 2012 · 43 citations · Full text

Chemoprevention Strategy, Immunology, Gastroenterology +16

The GLP-2 analogue elsiglutide reduces diarrhoea caused by the tyrosine kinase inhibitor lapatinib in rats

Bronwen J. Mayo, Kate R. Secombe, Anthony Wignall et al. · Cancer Chemotherapy and Pharmacology · 2020 · 34 citations

Glp-2 Analogue Elsiglutide, Gastrointestinal Pharmacology, Medicine +3

Determining the mechanisms of lapatinib-induced diarrhoea using a rat model

Joanne M. Bowen, Bronwen J. Mayo, Erin Plews et al. · Cancer Chemotherapy and Pharmacology · 2014 · 30 citations

Gastrointestinal Pharmacology, Medicine, Gastroenterology +4

Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling

Kathleen I. Pishas, Susan J. Neuhaus, Mark Clayer et al. · Cancer Research · 2013 · 25 citations · Full text

Tp53 Status, Nutlin-3a Efficacy, Malignant Disease +15